Daiwa Securities Group Inc. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 2 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$15,000
+114.3%
2140.0%0.00%
Q2 2022$7,0000.0%2140.0%0.00%
Q1 2022$7,000
+16.7%
2140.0%0.00%
Q4 2021$6,000
+20.0%
2140.0%0.00%
Q3 2021$5,000
+25.0%
214
+84.5%
0.00%
Q2 2021$4,000
-20.0%
1160.0%0.00%
Q1 2021$5,0000.0%1160.0%0.00%
Q4 2020$5,000
-73.7%
116
-66.7%
0.00%
Q3 2020$19,000
+11.8%
348
+2.4%
0.00%
Q2 2020$17,0000.0%3400.0%0.00%
Q1 2020$17,000
-37.0%
3400.0%0.00%
Q4 2019$27,000
+42.1%
340
-11.0%
0.00%
Q3 2019$19,0000.0%382
+6.7%
0.00%
Q2 2019$19,0000.0%3580.0%0.00%
Q1 2019$19,000
+90.0%
358
+48.5%
0.00%
Q4 2018$10,000
+11.1%
2410.0%0.00%
Q3 2018$9,000
-18.2%
2410.0%0.00%
Q2 2018$11,000
-8.3%
2410.0%0.00%
Q1 2018$12,0002410.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders